2,662 results on '"MIYAKE, HIDEAKI"'
Search Results
152. Non-significant impact of proteinuria on renal function in Japanese patients with metastatic renal cell carcinoma treated with axitinib
153. Partial nephrectomy for hilar tumors: comparison of conventional open and robot-assisted approaches
154. Enhanced sensitivity to sorafenib by inhibition of Akt1 expression in human renal cell carcinoma ACHN cells both in vitro and in vivo
155. Significant impact of R.E.N.A.L. nephrometry score on changes in postoperative renal function early after robot-assisted partial nephrectomy
156. Hyponatremia as a powerful prognostic predictor for Japanese patients with clear cell renal cell carcinoma treated with a tyrosine kinase inhibitor
157. Improved health-related quality of life of patients with metastatic renal cell carcinoma treated with a 2 weeks on and 1 week off schedule of sunitinib
158. Thyroid size change by CT monitoring after sorafenib or sunitinib treatment in patients with renal cell carcinoma: Comparison with thyroid function
159. Preoperative differentiation between benign and malignant renal masses smaller than 4 cm treated with partial nephrectomy
160. Expression profile of E-cadherin and N-cadherin in non-muscle-invasive bladder cancer as a novel predictor of intravesical recurrence following transurethral resection
161. Orthotopic bladder substitution following radical cystectomy in women: Comparative study between sigmoid and ileal neobladders
162. Comprehensive assessments of immuno‐oncology drug‐based combination therapies as first‐line treatment for advanced renal cell carcinoma
163. Summary of the Clinical Practice Guidelines for Penile Cancer 2021 by the Japanese Urological Association
164. MP27-07 COMPARISON OF CLINICAL OUTCOMES BETWEEN ANDROGEN DEPRIVATION THERAPY WITH UP-FRONT ABIRATERONE AND BICALUTAMIDE FOR JAPANESE PATIENTS WITH LATITUDE HIGH-RISK PROSTATE CANCER IN A REAL-WORLD MULTICENTER ANALYSIS
165. Significant impact of a history of prior or concomitant upper urinary tract cancer on the recurrence and progression of non-muscle invasive bladder cancer
166. Bladder cancer prospective cohort study on high‐risk non‐muscle invasive bladder cancer after photodynamic diagnosis‐assisted transurethral resection of the bladder tumor (BRIGHT study)
167. Assessment of postoperative quality of life: comparative study between laparoscopic and minimum incision endoscopic radical prostatectomies
168. Efficacy and tolerability of TIP (paclitaxel, ifosfamide and cisplatin) incorporated into induction chemotherapy for patients with intermediate- or poor-risk metastatic germ cell tumors
169. Long-term changes in renal function outcomes following radical cystectomy and urinary diversion
170. Expression of cell cycle-associated proteins in non-muscle-invasive bladder cancer: Correlation with intravesical recurrence following transurethral resection
171. Reduction of residual tumors by photodynamic diagnosis-assisted TURBT using 5-aminolevulinic acid for high-risk nonmuscle-invasive bladder cancer (BRIGHT study).
172. Limited impact of erectile function on health‐related quality of life in Japanese men undergoing robot‐assisted radical prostatectomy
173. Feasibility of interaortocaval clamping for renal artery during robot‐assisted right partial nephrectomy: A propensity score‐matching analysis
174. Robot‐assisted radical nephrectomy and inferior vena cava tumor thrombectomy: Initial experience in Japan
175. New year's greetings
176. Effects of Changes in Erectile Function After Holmium Laser Enucleation of the Prostate on Postoperative Outcomes in Patients With Benign Prostatic Hyperplasia
177. Useful predictors of progression‐free survival for Japanese patients with LATITUDE‐high‐risk metastatic castration‐sensitive prostate cancer who received upfront abiraterone acetate
178. Assessment of health-related quality of life in Japanese patients with metastatic renal cell carcinoma during treatment with tyrosine kinase inhibitors
179. Improved survival in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy in the era of targeted therapy
180. Assessment of efficacy, safety and quality of life of 55 patients with metastatic renal cell carcinoma treated with temsirolimus: a single-center experience in Japan
181. Assessment of efficacy, safety and quality of life of 110 patients treated with sunitinib as first-line therapy for metastatic renal cell carcinoma: experience in real-world clinical practice in Japan
182. Expression level of phosphorylated-4E-binding protein 1 in radical nephrectomy specimens as a prognostic predictor in patients with metastatic renal cell carcinoma treated with mammalian target of rapamycin inhibitors
183. CLUSTERIN INHIBITION USING OGX-011 SYNERGISTICALLY ENHANCES ANTITUMOUR ACTIVITY OF AXITINIB IN A HUMAN RENAL CELL CARCINOMA MODEL: MP92-08
184. IRINOTECAN AND NEDAPLATIN AS SALVAGE THERAPY FOR PATIENTS WITH ADVANCED GERM CELL TUMOR FOLLOWING INTENSIVE TREATMENT WITH CISPLATIN-BASED COMBINATION CHEMOTHERAPIES: MP81-20
185. THE ROLE OF UROCORTIN IN THE APOPTOSIS OF GERM CELLS AFTER EXPERIMENTAL TESTICULAR ISCHEMIA-REPERFUSION IN THE RAT: MP70-19
186. SEMINAL LEVEL OF CLUSTERIN IN INFERTILE MEN AS A SIGNIFICANT BIOMARKER REFLECTING SPERMATOGENESIS: MP70-18
187. MOLECULAR MECHANISM MEDIATING CYTOTOXIC ACTIVITY OF CABAZITAXEL IN DOCETAXEL-RESISTANT HUMAN PROSTATE CANCER CELLS: MP62-04
188. ENHANCED SENSITIVITY TO NVP-BEZ235 BY INHIBITION OF P62/SQSTM1 IN HUMAN BLADDER CANCER KOTCC-1 CELLS BOTH IN VITRO AND IN VIVO: MP61-11
189. HEALTH-RELATED QUALITY OF LIFE AFTER RADICAL CYSTECTOMY: COMPARATIVE STUDY BETWEEN ORTHOTOPIC SIGMOID VERSUS ILEAL NEOBLADDERS: MP56-18
190. THE COMPARISON OF ERECTILE FUNCTION BETWEEN RADICAL NEPHRECTOMY GROUP AND PARTIAL NEPHRECTOMY GROUP.: MP47-10
191. RENAL FUNCTION AND PERIOPERATIVE OUTCOMES OF SELECTIVE VERSUS COMPLETE RENAL ARTERIAL CLAMPING DURING ROBOT-ASSISTED PARTIAL NEPHRECTOMY USING CONSOLE-INTEGRATED REAL-TIME THREE-DIMENSIONAL IMAGE OVERLAY NAVIGATION: MP41-15
192. ASSESSMENT OF TIME-DEPENDENT CHANGES IN SEMEN PARAMETERS IN INFERTILE MEN FOLLOWING MICROSURGICAL VARICOCELECTOMY: PD07-01
193. EXPRESSION LEVELS OF PD-L1 AND PD-L2 EXPRESSION IN RADICAL NEPHRECTOMY SPECIMENS AS PROGNOSTIC PREDICTORS IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH TYROSINE KINASE INHIBITORS: PD04-11
194. PROGNOSTIC SIGNIFICANCE OF TUMOR EXTENT INTO THE VENOUS SYSTEM IN PATIENTS UNDERGOING SURGICAL TREATMENT FOR RENAL CELL CARCINOMA WITH VENOUS TUMOR THROMBUS: PD04-08
195. Bladder Neck Muscle Degeneration in Patients with Prostatic Hyperplasia
196. Predictive factors of de novo overactive bladder in clinically localized prostate cancer patients after robot‐assisted radical prostatectomy.
197. Computed diffusion-weighted imaging using 3-T magnetic resonance imaging for prostate cancer diagnosis
198. Efficacy and safety of temsirolimus in Japanese patients with metastatic renal cell carcinoma on hemodialysis
199. Sequential use of mammalian target of rapamycin inhibitors in patients with metastatic renal cell carcinoma following failure of tyrosine kinase inhibitors
200. Prognostic factors for non‑metastatic castration‑resistant prostate cancer treated with androgen receptor signaling inhibitors.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.